/
Omnicell, a leading healthcare technology provider focused on empowering autonomous medication management, is committed to solving the critical challenges inherent in medication management and elevating the role of clinicians within healthcare as an essential component of care delivery. Omnicell is focused on helping its customers define and deliver a cost-effective medication management strate…
Operating margin is thin at 0.44%. Limited cushion if revenue slows or costs rise, not the profile of a wide-moat business.
Revenue grew 6.5%, steady but not accelerating. Free cash flow declined 43% despite revenue growth, conversion is weakening.
Free cash flow declined 43% versus the prior year, cash generation momentum has weakened.
Profitability & Returns
Revenue (TTM)
$1.23B
▲ +6.5% YoY
Net Income (TTM)
$20M
▼ -83.6% YoY
Op. Margin
2.75%
▲ +0.4pp YoY
ROIC
1.83%
▲ +0.3pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
$114M
▼ -42.6% YoY
Op. Cash Flow (TTM)
$156M
▼ -32.2% YoY
Net Debt
-$37M
Net Cash Position
Cash & Equiv.
$239M
5Y CAGR: +5.8%
5Y CAGR: -11.8%
Continue Research